Similar to a double-edged sword, CXCL9 not only inhibits tumor growth by recruiting CTL, but also contributes to cancer proliferation by recruiting Tregs, TAMs, and MDSCs, which are involved in immune tolerance in tumors [42]. Here, CXCL9 is linked to neoplasm.